Bioxyne Ltd (PR8)

Overview

Bioxyne Limited is a vibrant player within the life sciences and consumer health products industry. Established in 1998, this company has carved out a niche for itself by focusing on the manufacture and distribution of an extensive array of consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines. With its operational footprint spanning the United Kingdom, Japan, Europe, and Australia, Bioxyne Limited has a diverse market presence. Moreover, the company's headquarters are strategically located in Sydney, Australia, enabling it to leverage the opportunities within and beyond the dynamic Asia-Pacific region. Notably, Bioxyne Limited extends its offerings through a blend of online platforms, wholesale, and direct sales channels in the United States and Asia, highlighting its robust reach and flexibility in distribution.

Products and Services

Bioxyne Limited's product portfolio and services are as broad as they are innovative, comprising:

• Plant-Based Wellness Products and Supplements: This category features a wide range of natural health solutions, including cannabinoids and cannabis extracts, vitamins, Manuka honey, skin care products, and mushroom complexes. These offerings underscore the company's commitment to harnessing the therapeutic potentials of natural ingredients for wellness and healthcare.
• Functional Food Products: Bioxyne Limited excels in developing functional food products with specific health benefits. Among its notable developments is the ingredient lactobacillus fermentum VRI-003, designed for gut health immune supplement products. These innovations represent the company's investment in research and development to deliver health-boosting food items to consumers.
• Research and Development Services: Beyond manufacturing, Bioxyne Limited plays a pivotal role in advancing health product research and development. The company offers specialized R&D services, underpinning its position as a forward-thinking entity in the health product landscape.
• Telemedicine Services: In alignment with modern healthcare trends, Bioxyne Limited provides telemedicine services, facilitating remote medical consultation and care. This service is a testament to the company’s adaptability to digital health advancements and its dedication to making healthcare accessible.
• BLS Clinics: As part of its telehealth offerings, Bioxyne Limited operates BLS Clinics, a telehealth platform. This initiative underscores the company’s commitment to leveraging technology in delivering healthcare solutions and consultations, bridging the gap between patients and medical professionals.